Clinical Trial

Transcranial Alternating Current Stimulation on Patients with Delirium and Critical Illness (DeliTACS)

Study acronym: DeliTACS
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if transcranial alternating current stimulation can shorten the duration of delirium in intensive care setting. The main question it aims to answer: * Is it possible to shorten the duration of delirium with transcranial alternating current stimulation? Researchers will compare experimental treatment to sham. Participants will receive experimental or sham treatment on maximum of two days depending on their delirium status. Duration of delirium is recorded and reported as "days alive and free of delirium".
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-06-10; most recent amendment 2024-10-02.
Status change: Not Yet Recruiting → Recruiting 2024-10-02
Trial Details
NCT Number NCT06460363
Lead Sponsor Kuopio University Hospital
Conditions Delirium
Enrollment 78 participants
Start Date 2024-09-06
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-04